B. Braun Completes Full Acquisition of True Digital Surgery to Advance Digital Microsurgery Technology
核心洞察
B. Braun SE (搜索) has completed the full acquisition of True Digital Surgery (搜索) (TDS), a California-based company specializing in digital robotic-assisted 3D surgical microscopy technology.
The acquisition enables B. Braun's surgical division Aesculap (搜索) to secure TDS expertise and advance the Aesculap AEOS (搜索) digital microscope used in neurosurgery, spinal surgery, and ENT procedures.
The high-end microsurgery market is transforming from traditional analog microscopes to digital exoscopes, which allow surgeons to operate while viewing 3D monitors and maintain upright posture to reduce physical strain.
B. Braun SE (搜索), a leading medical technology company, has completed the full acquisition of True Digital Surgery (搜索) (TDS), a Goleta, California-based specialist in digital robotic-assisted 3D surgical microscopy. The acquisition represents a strategic expansion of B. Braun's digital microsurgery capabilities and market presence in this rapidly evolving segment.
Strategic Integration of Digital Microscopy Technology
Prior to the full acquisition, B. Braun held a minority stake in TDS. The complete buyout allows B. Braun's surgical division Aesculap (搜索) to secure the valuable expertise of the TDS team and ensure continuous technological advancement of the Aesculap AEOS (搜索) digital microscope, one of B. Braun's core medical products used in neurosurgery, spinal surgery, and ENT surgery.
Dr. Jens von Lackum, member of the B. Braun executive board and responsible for the surgical division Aesculap (搜索), emphasized the strategic importance of the acquisition: "This strategic move enables us to integrate the cutting-edge technology and innovative capabilities of TDS. By combining the best of both worlds, we can continue to provide our customers with best-in-class systems in robotic assisted 3D microsurgery."
Market Transformation in Microsurgery
The high-end microsurgery market in neuro, spine and ENT surgery is undergoing a significant transformation, shifting from traditional analog microscopes to digital exoscopes. These digital, camera-based imaging systems provide excellent visualization at extreme angles and allow surgeons to operate while looking at 3D monitors instead of through an eyepiece.
This technological shift addresses critical ergonomic challenges in surgery. By removing the need to look through eyepieces, exoscopes enable surgeons to stand upright during procedures, reducing physical strain on the neck and back. According to research cited in the acquisition announcement, 74% of surveyed neurosurgeons have experienced work-related musculoskeletal disorders (搜索), with 12% requiring leave of absence, practice restriction, modification, or early retirement due to such conditions.
Technology and Innovation Focus
TDS, originally founded as TrueVision Systems in 2003, has developed technology specifically designed to address ergonomic shortcomings that can force surgeons out of the workforce. The company's system includes a camera mounted on a robotic arm, with images transmitted to a 3D surgical display.
Aidan Foley, former TDS CEO and Chairman of the Board, highlighted the significance of the merger: "This merger with such a highly respected healthcare organization as B. Braun represents an exciting new milestone for True Digital Surgery (搜索) and is a natural extension of the successful partnership we've enjoyed for several years. The combination of our groundbreaking technologies with B. Braun's access to the global healthcare market represents an incomparable opportunity for both companies to further improve the lives of patients and medical professionals the world over."
Operational Continuity and Growth Strategy
B. Braun plans for TDS to remain as a technology hub at its existing Goleta location. The acquisition structure is designed to allow TDS and its employees to focus on their core competencies of innovating and integrating advanced technologies while benefiting from B. Braun's global healthcare market access.
The purchase price for the acquisition has not been disclosed. B. Braun, with over 64,000 employees worldwide, generated 9.1 billion euros in sales in 2024, positioning the company as a significant player in the medical technology sector.
Competitive Landscape
The surgical exoscope market includes established players such as Carl Zeiss Meditec (搜索), Leica Microsystems (搜索), and Olympus. Recent surveys of neurosurgeons and orthopedic surgeons identified Olympus's Orbeye (搜索) and Meditec's Zeiss Kinevo 900 (搜索) as the two most widely used exoscopes in clinical practice.